HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of SkQ1 eye drops on the rat lens metabolomic composition and the chaperone activity of α-crystallin.

Abstract
The ability of SkQ1 eye drops to slow down the cataract development is demonstrated on the senescence-accelerated OXYS rats: the SkQ1 treatment leads to the considerable improvement of the lens condition as compared to the control group. The comparison of the chaperone activities of α-crystallins isolated from the rat lenses did not reveal significant difference between SkQ1-treated and control rats. The contents of major metabolites (23 compounds) in lenses of SkQ1-treated and untreated rats are also very similar, though the concentration of reduced glutathione (GSH) in lenses of SkQ1-treated rats is 12% lower. This difference may be attributed to the reduction of the oxidative stress under action of SkQ1 eye drops, and to the decreased requirement to produce high amounts of this antioxidant.
AuthorsL V Yanshole, V V Yanshole, O A Snytnikova, A Zh Fursova, N G Kolosova, Yu P Tsentalovich, R Z Sagdeev
JournalDoklady. Biochemistry and biophysics (Dokl Biochem Biophys) Vol. 464 Pg. 341-5 ( 2015) ISSN: 1608-3091 [Electronic] United States
PMID26518564 (Publication Type: Journal Article)
Chemical References
  • 10-(6'-plastoquinonyl)decyltriphenylphosphonium
  • Free Radical Scavengers
  • Ophthalmic Solutions
  • alpha-Crystallins
  • beta-Crystallins
  • Glutathione
  • Plastoquinone
Topics
  • Aging (drug effects, metabolism)
  • Animals
  • Cataract (drug therapy, metabolism)
  • Disease Models, Animal
  • Free Radical Scavengers (administration & dosage)
  • Glutathione (metabolism)
  • Kinetics
  • Lens, Crystalline (drug effects, metabolism)
  • Ophthalmic Solutions
  • Oxidative Stress (drug effects, physiology)
  • Plastoquinone (administration & dosage, analogs & derivatives)
  • Protein Multimerization
  • Rats
  • alpha-Crystallins (metabolism)
  • beta-Crystallins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: